These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6827446)

  • 1. Live and killed vaccines against toxoplasmosis in mice.
    Waldeland H; Frenkel JK
    J Parasitol; 1983 Feb; 69(1):60-5. PubMed ID: 6827446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to toxoplasmosis in hamsters.
    Elwell MR; Frenkel JK
    Am J Vet Res; 1984 Dec; 45(12):2668-74. PubMed ID: 6524761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the safety and efficacy of vaccination of nursing pigs with living tachyzoites of two strains of Toxoplasma gondii.
    Pinckney RD; Lindsay DS; Blagburn BL; Boosinger TR; McLaughlin SA; Dubey JP
    J Parasitol; 1994 Jun; 80(3):438-48. PubMed ID: 8195946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the adjuvant properties of Astragalus membranaceus and Scutellaria baicalensis GEORGI in the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
    Yang X; Huang S; Chen J; Song N; Wang L; Zhang Z; Deng G; Zheng H; Zhu XQ; Lu F
    Vaccine; 2010 Jan; 28(3):737-43. PubMed ID: 19887128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
    Khan IA; Casciotti L
    J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of mice with Neospora caninum: response to oral challenge with Toxoplasma gondii oocysts.
    Lindsay DS; Lenz SD; Dykstra CC; Blagburn BL; Dubey JP
    J Parasitol; 1998 Apr; 84(2):311-5. PubMed ID: 9576504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital toxoplasma challenge.
    McLeod R; Frenkel JK; Estes RG; Mack DG; Eisenhauer PB; Gibori G
    J Immunol; 1988 Mar; 140(5):1632-7. PubMed ID: 3346545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG-oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii.
    Kringel H; Dubey JP; Beshah E; Hecker R; Urban JF
    Vet Parasitol; 2004 Aug; 123(1-2):55-66. PubMed ID: 15265571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection and immunity with the RH strain of Toxoplasma gondii in rats and mice.
    Dubey JP; Shen SK; Kwok OC; Frenkel JK
    J Parasitol; 1999 Aug; 85(4):657-62. PubMed ID: 10461945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of cats with tissue cysts, bradyzoites, and tachyzoites of the T-263 strain of Toxoplasma gondii.
    Freyre A; Choromanski L; Fishback JL; Popiel I
    J Parasitol; 1993 Oct; 79(5):716-9. PubMed ID: 8410543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii.
    Khan IA; Matsuura T; Kasper LH
    J Immunol; 1998 Sep; 161(6):2994-3000. PubMed ID: 9743363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of resistance to toxoplasma in mice by pretreatment with attenuated vaccine.
    Nakayama I; Sato K
    Tokai J Exp Clin Med; 1980 Jul; 5(3):311-21. PubMed ID: 7194526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of cats against shedding of Toxoplasma oocysts.
    Frenkel JK; Smith DD
    J Parasitol; 1982 Oct; 68(5):744-8. PubMed ID: 7131181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-protection aginst Salmonella enteritidis infection in mice. I. Immunization trials.
    Padmanaban VD; Mittal KR
    Acta Microbiol Acad Sci Hung; 1979; 26(4):277-81. PubMed ID: 397731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
    Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
    Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of immunity to toxoplasmosis in pigs vaccinated with a nonpersistent strain of Toxoplasma gondii.
    Dubey JP; Baker DG; Davis SW; Urban JF; Shen SK
    Am J Vet Res; 1994 Jul; 55(7):982-7. PubMed ID: 7978639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii.
    Cong H; Gu QM; Yin HE; Wang JW; Zhao QL; Zhou HY; Li Y; Zhang JQ
    Vaccine; 2008 Jul; 26(31):3913-21. PubMed ID: 18555564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Toxoplasma cell fractions and mycobacterial immunostimulants against virulent Toxoplasma gondii in mice.
    Masihi KN; Brehmer W; Werner H
    Zentralbl Bakteriol Orig A; 1979; 245(3):377-86. PubMed ID: 44793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG-containing ODN has a limited role in the protection against Toxoplasma gondii.
    Saavedra R; Leyva R; Tenorio EP; Haces ML; Rodríguez-Sosa M; Terrazas LI; Hérion P
    Parasite Immunol; 2004 Feb; 26(2):67-73. PubMed ID: 15225293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.